fda_approval · anda · info
SAPTALIS PHARMS — ANDA approval: HYDROXYZINE HYDROCHLORIDE (unspecified)
- Event date
- 2026-06-11 00:00:00Z
- Observed
- 2026-07-09 22:53:25Z
- Source ID
- ANDA220271-1
- Payload hash
- 147c60c1235789dbd1f90cd2…
Summary
SAPTALIS PHARMS received ANDA approval for HYDROXYZINE HYDROCHLORIDE (unspecified) on 2026-06-11. Dosage form: SYRUP. Application #: ANDA220271.
Entities
Informational only. Not legal, financial, or medical advice.